↵* Corresponding Author: W. Schuette, Hospital Martha-Maria, Roentgenstr. 1, Halle-Dölau, 06120 Halle, Germany. Phone: 49-345-559-1440; Fax: 49-345-680-0376; E-mail: Wolfgang.Schuette{at}Martha-Maria.de W. Schuette and P. Schirmacher contributed equally to this article. Introduction: EGFR mutations confer sensitivity to EGFR tyrosine kinase inhibitors (TKI) in advanced non-small cell lung cancer (NSCLC).

READ FULL ARTICLE Curated publisher From cebp.aacrjournals.org